CDNA logo
CDNA NASDAQ US

CareDx, Inc. - Common Stock

Healthcare · Biotechnology Website · IPO Jul 2014
$18.31
▲ +$0.44 (+2.46%)
Vol 342K
10
Quality Score
ok
Deep Check
1/5 fail
Mkt Cap
$969.0M
P/E
15.9
ROE
17.4%
Margin
17.0%
D/E
0.00
Beta
2.54
52W
$11–$26

Wall Street Consensus

15 analysts · Apr 2026
5
Strong Buy
4
Buy
6
Hold
0
Sell
0
Strong Sell
60.0%
Buy Rating

Price Chart

Similar Stocks

CTMX
CytomX Therapeutics Inc
P/E 25.8
$721.8M
CMPX
Compass Therapeutics Inc.
$955.1M
AKTS
Aktis Oncology Inc
INBX
Inhibrx Biosciences Inc
$1.1B
JANX
Janux Therapeutics Inc
$830.0M
MPLT
MapLight Therapeutics Inc
$797.0M
ORIC
Oric Pharmaceuticals Inc
$796.6M
XNCR
Xencor Inc
$1.1B

Earnings

Beat rate: 50.0%
Quarter EPS Est EPS Act Surprise
Dec 2025 $0.24 $0.12 $-0.12
Sep 2025 $0.14 $0.28 +$0.14
Jun 2025 $0.12 $0.10 $-0.02
Mar 2025 $0.07 $0.09 +$0.02

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) 15.2% 15.2% 15.2% 15.2% 17.4% 17.4%
P/E (TTM) 21.05 11.92 14.97 15.45 14.76 15.95
Net Margin -9.9% 15.2% 15.2% 15.2% 17.0% 17.0%
Gross Margin 66.9% 66.9% 66.9% 66.9% 67.6% 67.6%
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 3.30 3.30 3.30 3.30 3.03 3.03

Key Ratios

ROA (TTM)
13.1%
P/S (TTM)
2.71
P/B
3.0
EPS (TTM)
$0.81
CF/Share
$-1.42
Rev Growth 3Y
+4.0%
52W High
$25.95
52W Low
$10.96
$10.96 52-Week Range $25.95

How does CDNA compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

CDNA AAPG ABEO ABOS ABP

CDNA valuation vs Biotechnology peers

P/E ratio
16.0
▼ 15% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
2.7
▼ 79% below peers (12.9)
vs Peers
vs Industry
Undervalued
P/B ratio
3.0
▲ 23% above peers (2.5)
vs Peers
vs Industry
Pricier
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

CDNA profitability vs Biotechnology peers

ROE
17.4%
▲ 126% above peers (-67.3%)
vs Peers
vs Industry
Top tier
Net margin
17.0%
▲ 106% above peers (-286.8%)
vs Peers
vs Industry
Below avg
Gross margin
67.6%
▼ 14% below peers (78.6%)
vs Peers
vs Industry
Weak
ROA
13.1%
▲ 128% above peers (-46.7%)
vs Peers
vs Industry
Top tier

CDNA financial health vs Biotechnology peers

D/E ratio
0.0
▼ 0% below peers (0.0)
vs Peers
vs Industry
Low debt
Current ratio
3.0
▼ 32% below peers (4.4)
vs Peers
vs Industry
Low liquidity
Beta
2.5
▲ 162% above peers (1.0)
vs Peers
vs Industry
More volatile

CDNA fundamentals radar

CDNA Peer median Industry

CDNA profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

CDNA vs peers: key metrics

Latest News

No related news yet